The mechanism of PKM2/HIF-1α axis polarizing TAMs by upregulating glucose-serine metabolism to promote melanoma progression
Background: Melanoma is the most aggressive skin cancer. Tumor-associated macrophages (TAMs) promote melanoma progression through polarization, however, whether glucose-serine metabolism regulates TAMs polarization and the specific regulatory mechanism remain unclear. Methods: experiments were conducted to determine whether HIF-1α promotes melanoma progression by regulating TAMs polarization and to explore the regulatory mechanism of HIF-1α on glucose-serine metabolism and polarization in melanoma TAMs; Co-IP, immunofluorescence, and functional rescue experiments were used to verify the upstream regulatory factors of HIF-1α. Results: experimental results demonstrated that HIF-1α upregulated glucose-serine metabolism in melanoma TAMs, thereby driving their polarization toward the M2 phenotype and consequently promoting tumor progression. PKM2 acted as an upstream regulatory factor of HIF-1α, and the PKM2/HIF-1α axis upregulated glucose-serine metabolism in TAMs to induce polarization. Additionally, a self-reinforcing circuit regulatory relationship among PKM2/HIF-1α/serine was identified within melanoma TAMs. Conclusions: Our study reveals that the PKM2/HIF-1α axis upregulates glucose-serine metabolism to induce M2 polarization of TAMs and drive melanoma progression. Targeting this metabolic axis thus holds promise as a novel therapeutic strategy for melanoma patients.
Authors
- Ying Sun (ORCID: https://orcid.org/0000-0003-0826-8338)
- Ying Yang (ORCID: https://orcid.org/0000-0002-9799-3293)
- X. William Yang (ORCID: https://orcid.org/0000-0003-3705-7935)
- Jiawei Yang
- Ching‐yu Chen (ORCID: https://orcid.org/0000-0002-1656-3436)
- Na Liang (ORCID: https://orcid.org/0000-0002-7758-4345)
- Chunming Li
- Peng Su
- Xiang Huang
- Hua Chen
- Neng Zhang
Institutions
- Zunyi Medical University (CN)
- People's Hospital of Kaizhou District (CN)
- Affiliated Hospital of Zunyi Medical College (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-31
- DOI
- https://doi.org/10.3389/fimmu.2026.1740155
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00